Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
AI channel feed
How two academic chemists turned San Diego startup Iambic into an AI force
11 months ago
In Focus
AI drug discovery startup goes public in Hong Kong, nabbing $115M to build on pharma partnerships
11 months ago
Financing
China
AI is unlikely to take off among CDMOs at the same scale as biopharma companies, insiders say
11 months ago
Manufacturing
Exclusive: Inspired by Spinraza, startup raises $25M for cancer drug targets created by alternative RNA splicing
11 months ago
Financing
Merck KGaA continues AI drug discovery deal spree with Biolojic Design
11 months ago
Deals
Sanofi, OpenAI, Formation Bio announce AI drug development partnership
Last year
Deals
R&D
AI biotech Exscientia to trim nearly a quarter of workforce, following pipeline cut and CEO firing
Last year
People
The Endpoints Slack interview: Siddhartha Mukherjee on the doctor-writer worldview, AI, and the future of cancer
Last year
R&D
In Focus
Exclusive: Harvard startup raises $26M, strikes three pharma partnerships for AI antibody design
Last year
Deals
'Bigger, faster, better': Isomorphic, DeepMind unveil AlphaFold 3, going beyond protein predictions
Last year
R&D
The next generation of AI biotechs is here. Can they deliver on the hype?
Last year
R&D
Exclusive: Marc Tessier-Lavigne on leaving Stanford and joining biotech’s new AI mega-startup
Last year
People
Startups
Why VC legend Bob Nelsen is making the biggest initial bet of his 37-year career on Xaira
Last year
People
Startups
AI drug discovery startup BenevolentAI cuts 30% of staff, closes US office
Last year
People
A majority of pharma and biotech companies prohibit ChatGPT use, survey finds
Last year
Pharma
Cash, chips and talent: Inside Nvidia's plan to dominate biotech's AI revolution
Last year
R&D
In Focus
Exclusive: Ex-Recursion team launches Leash Bio, challenging AI field with its bet on needing more data
Last year
Financing
ARPA-H calls on AI developers to help tackle cyberattacks
Last year
FDA+
Health Tech
Exclusive: ‘If you could hallucinate a protein’: Profluent snags $35M for generative AI models
Last year
Financing
Startups
David Baker’s lab shows generative AI can design antibodies. But are they good enough to become drugs?
Last year
R&D
‘An AI foundry’: Nvidia’s Jensen Huang pitches biotech on easy AI, with focus on software going beyond chips
Last year
Novo Nordisk Foundation backs effort to build supercomputer with Nvidia
Last year
R&D
FDA lays out cross-agency efforts on regulating AI in medical products
Last year
Pharma
FDA+
Exclusive: ‘ChatGPT for DNA’: Relation nabs $35M, with Nvidia backing, for osteoporosis work
Last year
Financing
Startups
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page